BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li HY, Xie Y, Yu TT, Lin YJ, Yin ZY. Durable response to pulsatile icotinib for central nervous system metastases from EGFR-mutated non-small cell lung cancer: A case report. World J Clin Cases 2020; 8(2): 370-376 [PMID: 32047787 DOI: 10.12998/wjcc.v8.i2.370]
URL: https://www.wjgnet.com/2307-8960/full/v8/i2/370.htm
Number Citing Articles
1
Iris M Goldstein, Laila C Roisman, Shoshana Keren-Rosenberg, Julia Dudnik, Hovav Nechushtan, Ilan Shelef, Vered Fuchs, Waleed Kian, Nir Peled. Dose escalation of osimertinib for intracranial progression in EGFR mutated non-small-cell lung cancer with brain metastasesNeuro-Oncology Advances 2020; 2(1) doi: 10.1093/noajnl/vdaa125
2
Shaofeng Su, Hongxian Wu, Jingfan Zhou, Guangwei Yuan, Haibo Wang, Jie Feng. Kinetic Characteristics of Curcumin and Germacrone in Rat and Human Liver Microsomes: Involvement of CYP EnzymesMolecules 2022; 27(14): 4482 doi: 10.3390/molecules27144482
3
David J.H. Bian, Anna-Maria Lazaratos, Sarah M. Maritan, Andrea Quaiattini, Zhimin Zeng, Zhengfei Zhu, Ugur Sener, Rachna Malani, Yu Jung Kim, Eiki Ichihara, Victor Cohen, April A.N. Rose, Nathaniel Bouganim, Matthew Dankner. Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysissHeliyon 2024; 10(9): e29668 doi: 10.1016/j.heliyon.2024.e29668